United States · FDA National Drug Code directory

Lubiprostone

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0480-4138_22f53da2-2fb9-411d-baad-fef011383f6f
Product NDC: 0480-4138
Form: CAPSULE, GELATIN COATED
Composition / generic term: Lubiprostone
Labeler: Teva Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20230103
Source listing expiry: 20261231

Source-listed ingredients

LUBIPROSTONE — 24 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

60 CAPSULE, GELATIN COATED in 1 BOTTLE (0480-4138-06) · 0480-4138-06

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →